LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "xcl1" as a keyword



Photo by cdc from unsplash

Molecular vaccine prepared by fusion of XCL1 to the multi-epitope protein of foot-and-mouth disease virus enhances the specific humoural immune response in cattle

Sign Up to like & get
recommendations! Published in 2017 at "Applied Microbiology and Biotechnology"

DOI: 10.1007/s00253-017-8523-y

Abstract: Targeting antigen to dendritic cells (DCs) is a promising way to manipulate the immune response and to design prophylactic molecular vaccines. In this study, the cattle XCL1, ligand of XCR1, was fused to the type… read more here.

Keywords: response; xcl ob7; xcl; molecular vaccine ... See more keywords
Photo by sharonmccutcheon from unsplash

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study

Sign Up to like & get
recommendations! Published in 2017 at "Annals of Hematology"

DOI: 10.1007/s00277-017-3142-3

Abstract: There is no information about XCL1 in patients with acute lymphoblastic leukemia (ALL). The objective of this study was to correlate the serum levels of XCL1 and survival in ALL patients. Only ALL patients older… read more here.

Keywords: serum xcl1; patients acute; lymphoblastic leukemia; serum ... See more keywords

A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells

Sign Up to like & get
recommendations! Published in 2018 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2018.02775

Abstract: The chemokine receptor XCR1 is known to be selectively expressed by cross-presenting dendritic cells (DCs), while its ligand XCL1/lymphotactin is mainly produced by activated CD8+ T cells and natural killer cells. Recent studies have shown… read more here.

Keywords: v21c a59c; cd8; mxcl1 v21c; cd8 cells ... See more keywords
Photo by nci from unsplash

Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19

Sign Up to like & get
recommendations! Published in 2022 at "Vaccines"

DOI: 10.3390/vaccines10030407

Abstract: SARS-CoV-2 spike (S) variants that may evade antibody-mediated immunity are emerging. Evidence shows that vaccines with a stronger immune response are still effective against mutant strains. Here, we report a targeted type 1 conventional dendritic… read more here.

Keywords: cov spike; fusion dna; xcl1; vaccine ... See more keywords